Centiva Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200
| Closed | -$14K | – | 1213 |
|
|
2022
Q3 | $14K | Sell |
200
-825
| -80% | -$57.8K | ﹤0.01% | 901 |
|
|
2022
Q2 | $69K | Buy |
+1,025
| New | +$69K | ﹤0.01% | 1029 |
|
|
2021
Q4 | – | Sell |
-1,071
| Closed | -$189K | – | 1181 |
|
|
2021
Q3 | $189K | Sell |
1,071
-3,645
| -77% | -$643K | 0.01% | 738 |
|
|
2021
Q2 | $762K | Sell |
4,716
-641
| -12% | -$104K | 0.02% | 402 |
|
|
2021
Q1 | $918K | Buy |
5,357
+1,051
| +24% | +$180K | 0.04% | 217 |
|
|
2020
Q4 | $946K | Buy |
4,306
+2,649
| +160% | +$582K | 0.04% | 161 |
|
|
2020
Q3 | $275K | Sell |
1,657
-5,402
| -77% | -$897K | 0.02% | 374 |
|
|
2020
Q2 | $806K | Buy |
+7,059
| New | +$806K | 0.05% | 119 |
|